Multiple Sclerosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with a relapsing form of multiple sclerosis (MS), including relapsing-remitting MS or secondary progressive MS
- You are able to walk on your own (on flat ground)
- You have not had an MS relapse (flare-up) in at least the past month
- You are between 18 and 75 years old
- If you take a medication called dalfampridine (sometimes known as Ampyra), you have been on the same daily dose for at least 2 months before the screening visit
Who may not be able to join:
- You have bone fractures, joint or muscle injuries, past surgeries, or any other physical conditions that affect your ability to walk or bear weight on your legs
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Milap Sandhu, PhD, Shirley Ryan AbilityLab
Phone: 312-328-7503
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Kinematics of the gait cycle
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.